India: Sun Pharma to acquire Concert Pharmaceuticals shares for US$576m

Indian multinational pharmaceutical company, Sun Pharmaceutical Industries, is acquiring all outstanding shares of Concert Pharmaceuticals, a late-stage biotechnology company pioneering the use of deuterium in medicinal chemistry, through a tender offer for an upfront cash payment of US$8.00 per share of common stock in cash, or US$576m in equity value. Concert stockholders will also receive…

You must be a HMI Subscriber to view this content.

Subscribe Now »